Cabergoline

Back to search

Molecule Structure

Scientific Name

Cabergoline

Description of the Drug

Cabergoline is a dopamine receptor agonist used for the treatment of hyperprolactinemic conditions due to various causes.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-02-07 from
http://www.drugbank.ca/drugs/DB00248

Brand Name(s)

Cabaser, Cabergoline, Dostinex

Company Owner(s)

Mylan Pharmaceuticals Inc, Actavis Laboratories Fl Inc, Impax Laboratories Inc, Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa, Ingenus Pharmaceuticals Llc, Apotex Corp, Pfizer Inc, Par Pharmaceutical Inc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Dopamine D2 receptor SINGLE PROTEIN AGONIST CHEMBL217

Unichem Links

SureChEMBL SCHEMBL42292
PharmGKB PA448708
Human Metabolome Database HMDB0014393
DrugBank DB00248
PubChem: Thomson Pharma 14808642 14759961
PubChem 54746
LINCS LSM-3939
Nikkaji J134.029H
EPA CompTox Dashboard DTXSID6022719
DrugCentral 460
ChemicalBook CB0282495
Guide to Pharmacology 37
GSRS 597c8ee0-b354-4ac9-93f9-99a3ac360ff2
rxnorm CABERGOLINE
PubChem: Drugs of the Future 12013713
KEGG Ligand C08187
ChEBI 3286
ZINC ZINC000003800008